SCHEMBL21863287

SCHEMBL21863287

Cc1ccc(-n2cc(Cn3ccnc3C3CC3)nn2)cc1C

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17502320 0.90 KCNH2 (1.00) KCNH2
SCHEMBL17502242 0.90 KCNH2 (1.00) KCNH2
SCHEMBL17502251 0.90 KCNH2 (1.00) KCNH2
SCHEMBL17502317 0.84 KCNH2 (1.00) KCNH2
SCHEMBL17502236 0.82 KCNH2 (1.00) KCNH2
SCHEMBL17502334 0.81 KCNH2 (1.00) KCNH2
SCHEMBL17502232 0.81 KCNH2 (1.00) KCNH2
SCHEMBL17502252 0.80 KCNH2 (1.00) KCNH2
SCHEMBL17502256 0.80 KCNH2 (1.00) KCNH2
SCHEMBL17502321 0.79 KCNH2 (1.00) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3180329-B1 TRIAZOLES AS NR2B RECEPTOR INHIBITORS JANSSEN PHARMACEUTICALS INC (US) 2020-03-18 — — EP disclosed
Send feedback